The ISREC Foundation is pleased to announce the winners of the TANDEM 2026 call for projects.
This year, seven research groups working in Lausanne, Bern, Zurich, Basel and Fribourg were awarded TANDEM funding.
Each team, led jointly by a clinician and a basic research scientist, addresses a clinically relevant question from two perspectives: understanding the molecular mechanism and directly improving patient care.
Discover the scientists and their projects on our website by clicking here.
This coming weekend, the 27th edition of the hill climb race, planned by Team Girard, will take place in Corcelles-le-Jorat.
This race, organized by vintage motorcycle enthusiasts, has also become a wonderful charity event over the years, with a portion of the proceeds going to the ISREC Foundation.
A huge THANK-YOU to the organizers, volunteers and riders for their unwavering commitment and invaluable support of cancer research.
The ISREC Foundation was delighted to welcome students taking part in the SUR-SRP program to AGORA.
The visit provided an opportunity for these young people to discover a unique research environment in which scientists and clinicians collaborate closely to further cancer research.
Fostering curiosity, opening the doors to our labs and inspiring research careers are major components of our commitment to the fight against cancer.
Since June 18th, 1964, we have been guided by the same conviction: to advance cancer research and to translate findings into genuine progress for patients.
Today more than ever, our commitment lies at the interface between research and clinical practice, so as to encourage breakthroughs that make a tangible difference.
Thank you to all who make this possible!
Find out more about our activities and the projects we support.
Link to the annual report 2025
The ISREC Foundation is pleased to see the work performed by teams from the University of Geneva, the CHUV (Centre hospitalier universitaire vaudois) and the FBM UNIL (Faculty of Biology and Medicine of the University of Lausanne) published in Cell Reports.
Supported through our TANDEM program, this project opens new avenues to better understand T cell activity in immunooncology and illustrates the value of collaborations between basic and clinical research in promoting scientific progress. Congratulations to Dr. Benita Wolf, Dr. Virginie Hamel and all the teams involved.
For more information: An unprecedented view of the immune system’s killer cells – Medias – UNIGE
Warm congratulations to Prof. Susan M. Gasser on her election to the American Academy of Arts & Sciences.
This prestigious distinction honors an outstanding scientific career and a longstanding commitment to advancing research. We are proud to see our Director receive this recognition.
INVITATION
Projection : Espoir, vie et cancer
Mercredi 29 avril 2026 à 17h30
La Ligue vaudoise contre le cancer et la Fondation ISREC ont le plaisir de vous inviter à la projection du film documentaire « Tant qu’il y a de l’espoir, il y a de la vie », le mercredi 29 avril 2026 à AGORA, Lausanne.
Un moment fort autour de la vie avec le cancer, suivi d’un échange avec Diana, protagoniste du documentaire, la Dre Ana Dolcan, le Prof. Friedrich Stiefel, le Prof. Mikaël Pittet et la réalisatrice Jeanne Gerster, puis d’un apéritif.
Entrée libre, inscription obligatoire.
Informations, programme complet et inscription ici
We are delighted to congratulate Prof. Elisa Oricchio on her appointment as a full professor at the EPFL.
We are particularly proud to have contributed to the start of her career by supporting her tenure track chair, and to be witnessing the recognition of her professional development, commitment and research excellence.
Congratulations on this outstanding achievement!
For more information Three promotions in the Life Sciences – EPFL
A recent study conducted by Prof. Pittet’s research team has led to the identification of a key parameter of the immune system that can help predict poor outcomes in many types of cancer. Prof. Pittet’s chair is supported by the ISREC Foundation.
These findings enhance our understanding of the immune mechanisms at work in cancer and offer significant opportunities for translational research.
Congratulations to the entire research team for achieving this significant contribution.
To find out more, read the full article here: Ludwig Cancer Research